Gastroparesis Drug Trends and Forecast
The future of the global gastroparesis drug market looks promising with opportunities in the diabetic gastroparesis, idiopathic gastroparesis, and post-surgical gastroparesis markets. The global gastroparesis drug market is expected to grow with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increase in number of surgeries, rising incidence rate of the diabetic population, and launch of innovative medications designed to manage symptoms like nausea and vomiting.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Gastroparesis Drug by Segment
The study includes a forecast for the global gastroparesis drug by drug class, disease type, distribution channel, and region.
Gastroparesis Drug Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
• Prokinetic Agents
• Antiemetic Agents
• Botulinum Toxin Injections
• Diabetic Gastroparesis
• Idiopathic Gastroparesis
• Post-Surgical Gastroparesis
• Others
Gastroparesis Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Pharmacies
• Clinics
• e-Commerce
Gastroparesis Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Gastroparesis Drug Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gastroparesis drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gastroparesis drug companies profiled in this report include-
• Allergan
• Abbott Laboratories
• AstraZeneca
• Cadila Pharmaceuticals
• ETX Pharma
• Evoke Pharma
• GlaxoSmithKline
Gastroparesis Drug Market Insights
Lucintel forecasts that antiemetic agents is expected to witness the highest growth over the forecast period.
Within this market, idiopathic gastroparesis will remain the largest segment.
North America is expected to witness highest growth over the forecast period due to surge in aging population, along with an increasing number of surgical procedures.
Features of the Global Gastroparesis Drug Market
Market Size Estimates: Gastroparesis drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Gastroparesis drug market size by drug class, disease type, distribution channel, and region in terms of value ($B).
Regional Analysis: Gastroparesis drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug classes, disease types, distribution channels, and regions for the gastroparesis drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gastroparesis drug market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for gastroparesis drug market?
Answer: The global gastroparesis drug market is expected to grow with a CAGR of 4.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the gastroparesis drug market?
Answer: The major drivers for this market are increase in number of surgeries, rising incidence rate of the diabetic population and launch of innovative medications designed to manage symptoms like nausea and vomiting.
Q3. What are the major segments for gastroparesis drug market?
Answer: The future of the gastroparesis drug market looks promising with opportunities in the diabetic gastroparesis, idiopathic gastroparesis, and post-surgical gastroparesis markets.
Q4. Who are the key gastroparesis drug market companies?
Answer: Some of the key gastroparesis drug companies are as follows:
• Allergan
• Abbott Laboratories
• AstraZeneca
• Cadila Pharmaceuticals
• ETX Pharma
• Evoke Pharma
• GlaxoSmithKline
Q5. Which gastroparesis drug market segment will be the largest in future?
Answer: Lucintel forecasts that antiemetic agents is expected to witness the highest growth over the forecast period.
Q6. In gastroparesis drug market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to surge in aging population, along with an increasing number of surgical procedures.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the gastroparesis drug market by drug class (prokinetic agents, antiemetic agents, and botulinum toxin injections), disease type (diabetic gastroparesis, idiopathic gastroparesis, post-surgical gastroparesis, and others), distribution channel (hospitals, pharmacies, clinics, and e-commerce), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Gastroparesis Drug Market, Gastroparesis Drug Market Size, Gastroparesis Drug Market Growth, Gastroparesis Drug Market Analysis, Gastroparesis Drug Market Report, Gastroparesis Drug Market Share, Gastroparesis Drug Market Trends, Gastroparesis Drug Market Forecast, Gastroparesis Drug Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.